Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia

BACKGROUND: Methotrexate (MTX) and actinomycin D (ActD) have been used as first-line chemotherapy agents in the treatment of low-risk gestational trophoblastic neoplasia (GTN). Although low-risk GTN is considered a curable disease, its reported primary remission rates of 49 to 93% reflect the diffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikhhasani, Shahrzad, Abdolrazaghnejad, Aghdas, Mousavi, Azam Sadat, Akhavan, Setareh, Zamani, Narges, Feizabad, Elham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Babol University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878912/
https://www.ncbi.nlm.nih.gov/pubmed/36741497
http://dx.doi.org/10.22088/cjim.14.1.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878912/
https://www.ncbi.nlm.nih.gov/pubmed/36741497
http://dx.doi.org/10.22088/cjim.14.1.47

Ejemplares similares